Ronald Williams - Johnson Johnson Independent Director
| JNJ Stock | EUR 137.88 2.16 1.59% |
Director
Mr. Ronald A. Williams is an Independent Director of the Company. He served as Chairman and Chief Executive Officer of Aetna Inc. from 2006 to 2010, and as Chairman from 2010 until his retirement in April 2011. He is also an advisor to the private equity firm, Clayton, Dubilier Rice, LLC. In addition, Mr. Williams serves on the boards of MIT Corporationrationration, Peterson Institute for International Economics, the Advisory Board of Peterson Center on Healthcare and is Vice Chairman of the Board of Trustees of The Conference Board. Previously, Mr. Williams served on President Obama Management Advisory Board from 2011 to January 2017, as Chairman of the Council for Affordable Quality Healthcare from 2007 to 2010, and as Vice Chairman of The Business Council from 2008 to 2010. since 2011.
| Age | 68 |
| Tenure | 13 years |
Ronald Williams Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ronald Williams against Johnson Johnson stock is an integral part of due diligence when investing in Johnson Johnson. Ronald Williams insider activity provides valuable insight into whether Johnson Johnson is net buyers or sellers over its current business cycle. Note, Johnson Johnson insiders must abide by specific rules, including filing SEC forms every time they buy or sell Johnson Johnson'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ronald Williams over six months ago Acquisition by Ronald Williams of 467 shares of Boeing subject to Rule 16b-3 | ||
Ronald Williams over six months ago Acquisition by Ronald Williams of 1428 shares of Johnson Johnson subject to Rule 16b-3 | ||
Ronald Williams over six months ago Acquisition by Ronald Williams of 258 shares of Boeing subject to Rule 16b-3 | ||
Ronald Williams over six months ago Acquisition by Ronald Williams of 498 shares of Boeing subject to Rule 16b-3 |
Similar Executives
| Found 14 records | DIRECTOR Age | ||
| William Weldon | CVS Health | 69 | |
| Mary Schapiro | CVS Health | 62 | |
| Roger Farah | CVS Health | 65 | |
| Alecia DeCoudreaux | CVS Health | 62 | |
| David Brown | CVS Health | 66 | |
| JeanPierre Millon | CVS Health | 66 | |
| Mark Bertolini | CVS Health | 61 | |
| Richard Swift | CVS Health | 73 | |
| Fernando Aguirre | CVS Health | 61 | |
| Tony White | CVS Health | 70 | |
| Anne Finucane | CVS Health | 64 | |
| Edward Ludwig | CVS Health | 66 | |
| Richard Bracken | CVS Health | 64 | |
| NancyAnn DeParle | CVS Health | 61 | |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jennifer Doudna, Independent Director | ||
| Alex Gorsky, Chairman of the Board, CEO | ||
| William Perez, Independent Director | ||
| Michael Sneed, Executive Vice President - Global Corporate Affairs and Chief Communication Officer | ||
| Marillyn Hewson, Independent Director | ||
| Jorge Mesquita, Executive Vice President Worldwide Chairman - Consumer | ||
| Mary Coleman, Independent Director | ||
| Michael Ullmann, Vice President General Counsel | ||
| Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
| Kathy Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
| Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
| Mary Beckerle, Director | ||
| Sandra Peterson, Group Worldwide Chairman | ||
| Scott Davis, Director | ||
| Louise Mehrotra, Vice President Investor Relations | ||
| Ashley McEvoy, Executive Vice President - Worldwide Chairman, Medical Devices | ||
| Ronald Williams, Independent Director | ||
| Kathryn Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
| Anne Mulcahy, Lead Independent Director | ||
| Joseph Wolk, Vice President - Investor Relations | ||
| Thibaut Mongon, Executive Vice President Worldwide Chairman, Consumer | ||
| Ian Davis, Independent Director | ||
| Paulus Stoffels, Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group | ||
| Mark McClellan, Independent Director | ||
| Charles Prince, Independent Director | ||
| Eugene Washington, Independent Director | ||
| Dominic Caruso, CFO, Vice President - Finance | ||
| Peter Fasolo, Vice President - Global Human Resources | ||
| Susan Lindquist, Independent Director |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 443.95 B | |||
| Price To Book | 6.27 X | |||
| Price To Sales | 4.97 X | |||
| Revenue | 94.94 B | |||
| EBITDA | 28.97 B | |||
| Net Income | 17.94 B | |||
| Total Debt | 26.89 B | |||
| Cash Flow From Operations | 21.19 B | |||
| Price To Earnings To Growth | 3.86 X | |||
| Number Of Employees | 29 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |